Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Pharmacyte Biotech Inc (PMCB)

Pharmacyte Biotech Inc (PMCB)
1.6350 -0.0350 (-2.10%) 15:37 ET [NASDAQ]
1.5700 x 10 1.7000 x 1
Realtime by (Cboe BZX)
1.5700 x 10 1.7000 x 1
Realtime - - (-) -
Quote Overview for Fri, Mar 14th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5200
Day High
1.6800
Open 1.6500
Previous Close 1.6700 1.6700
Volume 24,678 24,678
Avg Vol 22,758 22,758
Stochastic %K 45.14% 45.14%
Weighted Alpha -20.01 -20.01
5-Day Change -0.1450 (-8.15%) -0.1450 (-8.15%)
52-Week Range 1.3900 - 2.5800 1.3900 - 2.5800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,470
  • Shares Outstanding, K 6,868
  • Annual Sales, $ 0 K
  • Annual Income, $ 330 K
  • EBIT $ -5 M
  • EBITDA $ -5 M
  • 60-Month Beta -0.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.29

Options Overview Details

View History
  • Implied Volatility 448.67% ( +25.50%)
  • Historical Volatility 65.15%
  • IV Percentile 70%
  • IV Rank 37.16%
  • IV High 1,144.99% on 01/16/25
  • IV Low 36.92% on 07/23/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 219
  • Open Int (30-Day) 215

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4700 +11.22%
on 03/12/25
Period Open: 1.6300
1.9000 -13.95%
on 02/21/25
+0.0050 (+0.31%)
since 02/14/25
3-Month
1.4500 +12.76%
on 02/10/25
Period Open: 1.7200
1.9000 -13.95%
on 02/21/25
-0.0850 (-4.94%)
since 12/13/24
52-Week
1.3900 +17.63%
on 08/27/24
Period Open: 2.0400
2.5800 -36.63%
on 03/27/24
-0.4050 (-19.85%)
since 03/14/24

Most Recent Stories

More News
PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan

PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box ® for potential...

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent Solicitation

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Reports Positive Interim Results in Malignant Ascites Mouse Model Study

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Announces Preliminary Unaudited Financial Results for Fiscal Year 2022

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
IROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO RECONSTITUTE PHARMACYTE BIOTECH BOARD OF DIRECTORS

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), announced that on Friday, July 8, 2022, that it had delivered a...

PMCB : 1.6350 (-2.10%)
IROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT ACTIONS BY THE PHARMACYTE BIOTECH BOARD OF DIRECTORS

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest stockholders of PharmaCyte Biotech, Inc....

PMCB : 1.6350 (-2.10%)
PharmaCyte Biotech Announces Additional Quality Control Assay and Confirms Stability of CypCap Cells

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes and malignant ascites using its signature live-cell encapsulation technology,...

PMCB : 1.6350 (-2.10%)
IROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED DIRECTOR CANDIDATES FOR ELECTION AT PHARMACYTE'S 2022 ANNUAL MEETING

/PRNewswire/ -- Iroquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest stockholders of PharmaCyte Biotech, Inc....

PMCB : 1.6350 (-2.10%)

Business Summary

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is...

See More

Key Turning Points

3rd Resistance Point 1.9300
2nd Resistance Point 1.8100
1st Resistance Point 1.7400
Last Price 1.6350
1st Support Level 1.5500
2nd Support Level 1.4300
3rd Support Level 1.3600

See More

52-Week High 2.5800
Fibonacci 61.8% 2.1254
Fibonacci 50% 1.9850
Fibonacci 38.2% 1.8446
Last Price 1.6350
52-Week Low 1.3900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals